# Hydrocortisone for BPD

> **NCT01353313** · PHASE3 · COMPLETED · sponsor: **NICHD Neonatal Research Network** · enrollment: 800 (actual)

## Conditions studied

- Infant, Newborn
- Infant, Small for Gestational Age
- Infant, Very Low Birth Weight
- Infant, Premature
- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** Hydrocortisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01353313
- **Lead sponsor:** NICHD Neonatal Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-11
- **Primary completion:** 2020-09-21
- **Final completion:** 2024-09-12
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2025-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01353313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01353313, "Hydrocortisone for BPD". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01353313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*